Drug fools immune system to fight allergy

September 29, 2006

A Swiss company is testing a hay fever drug that tricks the human immune system into acting as if it has been exposed to an infectious agent found in dirt.

Cytos Biotechnology has tested CYT 003-QbG10 on 10 people with hay fever and has found that their sensitivity to grass pollen is 1 percent after treatment to what it was before, New Scientist magazine reports. So far, the subjects have been free of hay fever for eight months.

A previous study found that people who are sensitive to dust mites have remained free of symptoms for at least a year.

The drug mimics the effect of exposure to mycobacteria, which somehow reboots the immune system, New Scientist said.

Copyright 2006 by United Press International

Explore further: The life-saving treatment that's being thrown in the trash

Related Stories

The life-saving treatment that's being thrown in the trash

March 28, 2017

A few hours before beginning chemotherapy, a man named Chris faces his cellphone camera with a mischievous smile and describes a perfectly absurd milestone at 1.37pm on a Wednesday. "There is no more beautiful moment in a ...

Surviving hay fever

November 17, 2014

Three million Australian adults – 15% of the population – struggle through spring and summer with watery eyes, running nose, itchy throat and the hallmark hay fever symptom, sneezing.

Australians trial Botox to treat hay fever

October 9, 2012

The best-selling wrinkle erasing drug Botox will be used in an Australian study to treat hay fever, researchers said Tuesday after it showed promise in providing relief in early trials.

State-of-the-science help for hay fever sufferers

February 2, 2015

Sublingual immunotherapy is one of several state-of-the-science treatments for allergic rhinitis, or "hay fever," being recommended by a panel of experts in a new guideline published Feb. 2, 2015, by the American Academy ...

Merck: New drugs pending approval or in late tests

May 6, 2014

Merck & Co. could get an impressive six new prescription medicines approved in the U.S. this year and will soon apply for regulatory approval of two others, company executives said Tuesday during a briefing on Merck's business.

Recommended for you

Experts question push for 'abuse-deterrent' Rx opioids

June 1, 2017

In response to the rise in opioid overdose deaths nationwide, pharmaceutical companies have developed formulations of prescription opioids designed to prevent tampering or abuse. These "abuse-deterrent" forms, however, are ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.